BETTER LIVING DONOR LIVER TRANSPLANTATION PATIENT SURVIVAL COMPARED TO DECEASED DONOR - A SYSTEMATIC REVIEW AND META-ANALYSIS.

Autor:	Cavalcante LN; Universidade Federal da Bahia, Departamento de Medicina, Salvador, BA, Brasil.; Hospital São Rafael - Rede Dor, Salvador, BA, Brasil., Queiroz RMT; Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brasil., Paz CLDSL; Universidade Federal da Bahia, Departamento de Medicina, Salvador, BA, Brasil., Lyra AC; Universidade Federal da Bahia, Departamento de Medicina, Salvador, BA, Brasil.; Hospital São Rafael - Rede Dor, Salvador, BA, Brasil.
Jazyk:	angličtina
Zdroj:	Arquivos de gastroenterologia [Arq Gastroenterol] 2022 Jan-Mar; Vol. 59 (1), pp. 129-136.
DOI:	10.1590/S0004-2803.202200001-22
Abstrakt:	Background: Deceased donor liver transplantation (DDLT) is the first choice, but living donor transplantation (LDLT) is an alternative to be considered in special situations, such as lack of donated organs and emergencies. So far, there is no consensus on which transplantation method provides better survival and fewer complications, which is still an open point for discussion. Methods: This meta-analysis compared the 1, 3, and 5-year patient and graft survival rates of LDLT and DDLT. We included studies published from April-2009 to June-2021 and adopted the generic model of the inverse of variance for the random effect of hazard ratios. The adequacy of the studies was determined using the Newcastle-Ottawa Scale - NOS (WELLS). Results: For patient survival analysis, we included a total of 32,258 subjects. We found a statistically significant better survival for the LDLT group at 1, 3 and 5 years, respectively: 1.35 HR (95%CI 1.10-1.66, P=0.005), 1.26 HR (95%CI 1.09-1.46, P=0.002) and 1.27 HR (95%CI 1.09-1.48, P=0.002). Our meta-analysis evaluated a total of 21,276 grafts. In the overall analysis, the 1-year survival was improved in favor of the LDLT group (1.36 HR, 95%CI 1.16-1.60, P<0.0001), while the 3-year survival (1.13 HR, 95%CI 0.96-1.33, P<0.13), and 5 (0.99 HR, 95%CI 0.74-1.33, P<0.96), did not differ significantly. Conclusion: This metanalysis detected a statistically significant greater 1-, 3- and 5-years patient survival favoring LDLT compared to DDLT as well as a statistically significant difference better 1-year graft survival favoring the LDLT group.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu